BIOMAT Database Logo BIOMAT Database Logo

DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. 1995

Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Mycobacteria Department, Statens Seruminstitut, Copenhagen, Denmark.

With the purpose of determining whether the risk of infection with a particular clone of Mycobacterium tuberculosis is influenced by the human immunodeficiency virus (HIV) status of the host, we analyzed and compared 68 mycobacterial isolates obtained from HIV-seropositive patients with tuberculosis (TB) in Dar es Salaam, Tanzania, with 66 mycobacterial isolates obtained from HIV-seronegative patients with TB in the same geographical region by using both DNA fingerprinting and classical phenotyping methods. One hundred one different IS6110 fingerprinting patterns were observed in the 134 isolates. The level of diversity of the DNA fingerprints observed in the HIV-seropositive group was comparable to the level of the diversity observed in the HIV-seronegative group. Resistance to a single anti-TB drug was found in 8.8% of the tested isolates, and 3.2% of the isolates were resistant to more than one anti-TB drug. The drug susceptibility profiles were not significantly difference between the two groups of isolates compared in the present study. Phenotypic characteristics which classify M. tuberculosis strains as belonging to the Asian subgroup correlated with a low IS6110 copy number per isolate. However, the occurrence of Asian subgroup strains was not associated with the HIV status of the patients. The results of the study suggested an equal risk of infection with a defined M. tuberculosis clone for HIV-seropositive and HIV-seronegative individuals.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004251 DNA Transposable Elements Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom. DNA Insertion Elements,DNA Transposons,IS Elements,Insertion Sequence Elements,Tn Elements,Transposable Elements,Elements, Insertion Sequence,Sequence Elements, Insertion,DNA Insertion Element,DNA Transposable Element,DNA Transposon,Element, DNA Insertion,Element, DNA Transposable,Element, IS,Element, Insertion Sequence,Element, Tn,Element, Transposable,Elements, DNA Insertion,Elements, DNA Transposable,Elements, IS,Elements, Tn,Elements, Transposable,IS Element,Insertion Element, DNA,Insertion Elements, DNA,Insertion Sequence Element,Sequence Element, Insertion,Tn Element,Transposable Element,Transposable Element, DNA,Transposable Elements, DNA,Transposon, DNA,Transposons, DNA
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania.
July 2008, BMC research notes,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
DNA restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from HIV-seropositive and HIV-seronegative patients in Kampala, Uganda.
February 2009, BMC infectious diseases,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Distinctiveness of Mycobacterium tuberculosis genotypes from human immunodeficiency virus type 1-seropositive and -seronegative patients in Lima, Peru.
April 2003, Journal of clinical microbiology,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
March 2013, BMC infectious diseases,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Investigation of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting.
June 2005, Indian journal of medical sciences,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.
August 1999, Infection and immunity,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
[Pulmonary tuberculosis: differences between patients seropositive and seronegative for the acquired immunodeficiency virus].
August 1993, Anales de medicina interna (Madrid, Spain : 1984),
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (TB).
December 1990, The Journal of the New York State Nurses' Association,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs.
November 2002, Emerging infectious diseases,
Z H Yang, and I Mtoni, and M Chonde, and M Mwasekaga, and K Fuursted, and D S Askgård, and J Bennedsen, and P E de Haas, and D van Soolingen, and J D van Embden
Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India.
April 2005, The Indian journal of medical research,
Copied contents to your clipboard!